Lease vs. Purchase for Medical Capital Equipment: A CFO's Decision Framework

A procurement-literate guide to structuring acquisitions of imaging, surgical, and clinical equipment in 2026 — with the tax, accounting, and lifecycle math that actually moves the needle.

Why this matters (specific scenarios)

The "lease vs. buy" question rarely produces a clean answer because the right answer depends on the asset's useful life, your tax posture, and your cost of capital — not on a vendor's payment table.

Consider four realistic scenarios CFOs face this year:

A 128-slice CT scanner with a publicly cited buy price of $385,000 versus a quoted lease of $6,950/month for 60 months with a $1 buyout. That 60-month structure totals roughly $417,000 — a ~$32,000 premium over cash purchase, before tax effects.
An ASC adding a second C-arm: useful life often exceeds 10 years, depreciation matters, and the unit will likely outlive any 5-year lease term.
A hospital lab swapping chemistry analyzers every 4–5 years as reagent contracts shift — classic lease territory.
A multi-site imaging group standardizing ultrasound across 12 clinics, where uniform monthly opex and synchronized refresh cycles outweigh ownership economics.

The OBBBA (One Big Beautiful Bill Act) of 2025 changed the calculus materially. The Act made significant changes to both Section 179 and bonus depreciation that went into effect in 2025, and when used together may allow businesses to deduct up to 100% of capital purchases. That single change tilts many borderline decisions toward purchase — but only if you have the taxable income to absorb the deduction.

The decisions that shape the outcome

1. Match the structure to the asset's useful life

Higher-cost, rapidly evolving equipment is often leased, while lower-cost or long-life equipment is more frequently purchased. A practical rule of thumb based on lease terms in the market: In the medical device market, the typical lease term is between three and five years, with the option to purchase, renew, extend, or return the equipment at the end of the initial term.

Lease (FMV/operating): chemistry/hematology analyzers, EHR-tied workstations, infusion pump fleets, ultrasound — anything where obsolescence risk is concentrated in years 4–7.
Buy or $1-buyout finance: surgical tables, autoclaves, anesthesia machines, dental chairs, digital radiography rooms — assets with 10–15+ year service lives and stable software/firmware footprints.

2. Know the four lease structures — and which one you're actually being offered

Vendors and lessors use overlapping terminology. The four to demand by name:

FMV (true/operating) lease. A fair market value lease is an operating lease, so it will not appear on your balance sheet and you don't enjoy the benefits or responsibilities of ownership. The monthly payments, however, are deductible as a business expense (rent) under the IRS regulations. Usually, the term of the FMV lease is not more than 75% of the equipment's expected lifetime. Lowest payments, highest end-of-term uncertainty.
$1 buyout (capital/finance) lease. A $1 buyout lease is a type of capital lease, which means you own the equipment or property throughout the life of the lease. The leased equipment will show up on your balance sheet as an asset. Effectively a loan in lease clothing.
10% PUT (Purchase Upon Termination). Lower monthly payments than $1 buyout, but mandatory residual purchase at term end.
TRAC lease. Vehicle-only (mobile imaging trailers, fleet vans). Both the lessor and the lessee agree to pay an estimated residual value, or TRAC value, which the lessee has to pay to the lessor at the end of the term. The TRAC value is inversely proportional to the fixed monthly payments. Normally, higher TRAC value leads to lower monthly payments and vice-versa.

The most common — and expensive — buyer error: signing an FMV lease assuming it works like a $1 buyout. FMV leases typically don't qualify [for Section 179] because the lessor retains ownership. 10% purchase option leases fall in a gray area — the IRS considers multiple factors. Always consult your CPA before assuming you can claim Section 179 on any lease.

3. Run the Section 179 + bonus depreciation math before signing

For 2025 and 2026, the deduction landscape is materially more generous than it was in 2024:

2025: For tax years beginning in 2025, the maximum Section 179 expense deduction is $2,500,000. This limit is reduced by the amount by which the cost of Section 179 property placed in service during the tax year exceeds $4,000,000.
2026: For tax years beginning in 2026, the maximum Section 179 expense deduction is $2,560,000. This limit is reduced by the amount by which the cost of Section 179 property placed in service during the tax year exceeds $4,090,000.
Bonus depreciation: Bonus depreciation is generally 100% for qualified property acquired and placed in service after Jan. 19, 2025.

A critical limitation often missed: Your Section 179 deduction cannot exceed your business taxable income for the year. This prevents creating or increasing a loss. This limitation doesn't apply to bonus depreciation, making bonus depreciation advantageous for businesses operating at a loss or with low taxable income.

For a non-profit hospital with no taxable income, these federal incentives are irrelevant — and the lease-versus-buy decision collapses to a pure cost-of-capital and balance-sheet question.

4. Model the ASC 842 balance sheet impact — operating leases no longer hide

This is where many practice owners and even hospital finance teams still under-model. Under ASC 842, all leases show up on the balance sheet, and the new rules also determine how those leases are listed. In general: All leases longer than 12 months are on balance sheet.

For healthcare entities specifically, the new standard impacts components of external and operational reporting beyond just recording all leases over 12 months as a right-of-use (ROU) asset and lease liability. For example, organizations need to review their service agreements for embedded leases. The change in financial reporting may also impact ratios that are used in debt covenants for current or prospective lending agreements.

Translation for CFOs: the historical "off-balance-sheet" advantage of operating leases is gone. Your debt-to-EBITDA, leverage ratios, and bond covenants now reflect lease liabilities. Discuss this with lenders before signing — proactively communicate changes in financials and applicable ratios as a result of ASC 842. Many financial institutions are aware of GAAP accounting changes and are open to discussing whether existing borrowing arrangements could be amended or restructured. The "frozen GAAP" clause may prevent the new standard from impacting debt covenants now, but the requirement to calculate ratios under legacy GAAP could become complicated in future years. Before entering into new debt agreements, ensure contract language excludes the impact of lease liabilities and other prospective accounting changes when complying with borrowing requirements.

5. Watch embedded leases in service contracts

Reagent-rental agreements, managed-print imaging contracts, and "free" placements with consumables minimums are often leases under ASC 842. Under ASC 842, ROU assets and lease liabilities with terms greater than 12 months must be recorded for all operating and finance leases. If three elements are present — an identifiable asset, the right to control the asset, and a contract that spans a period of time — then an arrangement may contain an embedded lease under ASC 842.

6. Price the service contract as carefully as the asset

For imaging, the OEM service contract often costs 8–12% of system price annually and dwarfs the lease/buy spread over 7 years. Lease quotes that "include maintenance" frequently include only first-year warranty. Get the year-by-year service schedule in writing before you compare totals.

Common mistakes (with concrete examples)

Comparing lease payment to loan payment, ignoring residual. A 60-month FMV lease at $6,950/mo on a $385,000 CT looks competitive — until the FMV buyout at month 61 is quoted at $75,000–$115,000.
Assuming Section 179 applies to any lease. Only $1-buyout/capital leases reliably qualify; FMV leases generally do not.
Modeling against pre-OBBBA depreciation rules. Legacy spreadsheets still using 60% bonus depreciation for 2024 understate the cash benefit of purchasing in 2025–2026 by tens of thousands.
Ignoring refurbished alternatives. For imaging, refurbished equipment prices can often be purchased at 30% – 70% of the cost of the original equipment , which can make outright purchase cheaper than any lease on a new unit.
Not pricing early termination. Early lease termination is typically expensive. Most leases require you to pay all remaining payments even if you return the equipment early. Some leases offer early buyout options at predetermined prices. A few include early termination clauses with penalties. Before signing any lease, ask specifically about early termination costs and get the calculation method in writing.

A practical workflow / checklist

Define expected service life. Use ECRI device profiles or AAMI guidance, not vendor marketing. The Health Devices Program (HDP) was established by ECRI in 1971 to conduct assessments that provide independent, objective judgment for selection, purchase, and use of medical instruments, equipment, and systems.
Pull at least three competitive quotes: cash purchase, $1-buyout finance lease, FMV operating lease.
Force vendors to break out equipment, install, training, first-year service, and software licensing line by line.
Run a 7- to 10-year NPV at your weighted average cost of capital (typically 5–9% for hospitals, 8–12% for private practices), including service contract escalators.
Apply the right tax treatment — check Section 179 eligibility with your CPA before relying on it.
Model the ASC 842 ROU asset and liability for any lease >12 months and check debt-covenant headroom.
Get end-of-term mechanics in writing: FMV definition, return conditions, de-installation costs, data wipe responsibility on connected devices.
Specify regulatory pass-through: who handles FDA recalls, IEC 60601-1 re-certification after major service, and software cybersecurity patches.

Edge cases worth flagging

Tax-exempt hospitals: Section 179 and bonus depreciation provide zero benefit. The decision becomes pure cost of capital plus balance-sheet management.
Physician-owned ASCs and imaging centers: pass-through taxation often makes the cash benefit of bonus depreciation immediate and substantial — often making purchase the dominant strategy in 2025–2026.
Equipment with high obsolescence risk (e.g., AI-enabled imaging, robotic surgical platforms with frequent software-tied upgrades): operating leases offload obsolescence risk to the lessor, even if total cost is higher.
Sale-leasebacks: A sale-leaseback is a unique equipment financing strategy where a business sells a piece of equipment to a leasing company and then leases it back. This allows businesses to free up capital while continuing to use their essential equipment. Useful for distressed liquidity events but rarely tax-optimal.
Embedded leases in reagent rental agreements: review every multi-year supply contract with finance before renewal — they may already be on your balance sheet.
Cross-border fleets (Canada/Mexico subsidiaries): IFRS 16 treats nearly all leases as finance leases, eliminating the operating-lease P&L smoothing available under U.S. GAAP.

There is no universal answer. The rigorous approach is asset-by-asset: model the after-tax NPV under both structures using your actual cost of capital, your actual tax position, and the manufacturer's actual service economics — then let the numbers, not the vendor's monthly payment, decide.

Sources

IRS Publication 946 (2025), How To Depreciate Property — Section 179 dollar limits for 2025 and 2026. https://www.irs.gov/publications/p946
U.S. Bank, Maximizing Your Deductions: Section 179 and Bonus Depreciation (2025) — OBBBA changes and 100% bonus depreciation reinstatement. https://www.usbank.com/financialiq/improve-your-operations/industry-insights/Maximizing-your-deductions-Section-179-and-Bonus-Depreciation.html
FASB ASC 842 — guidance summarized at U.S. Bank Equipment Finance and FinQuery; balance-sheet recognition of operating and finance leases.
Wipfli, ASC 842 Introduces Critical Lease Decisions for Healthcare Entities — embedded lease analysis for hospitals and clinics. https://wipfli.com/insights/blogs/health-care-perspectives-blog/what-asc-842-lease-accounting-means-for-healthcare
Becker's Hospital Review, What You Need to Know About Medical Equipment Financing and Leasing — typical 3–5 year medical lease terms.
ECRI Health Devices Program (NCBI Bookshelf) — independent device assessment methodology used in hospital procurement. https://www.ncbi.nlm.nih.gov/books/NBK218482/
Team Financial Group, Pathward, First Citizens Bank — definitions and structural distinctions among FMV, $1 buyout, TRAC, and PUT lease structures.
Global Electronics Council, Medical Imaging Equipment State of Sustainability Research (2022) — refurbished imaging pricing benchmarks (30–70% of new).
Crestmont Capital case study — published lease-vs-buy quote on a 128-slice CT ($385,000 buy / $6,950 × 60 months / $1 buyout).